Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet’s disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet’s disease. We retrospectively reviewed patients with intestinal Behçet’s disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908–0.982; P = 0.004), high disease activity index for intestinal Behçet’s disease score (adjusted OR, 1.111; 95% CI, 1.060–1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135–8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084–58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet’s disease.
Bibliographical noteFunding Information:
Funding information This research was supported by a grant (A120176) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health and Welfare, Republic of Korea; a grant (NRF-2017R1A1A1A05001011) from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science, ICTand Future Planning; and a faculty research grant (2012-31-0477) from the Department of Internal Medicine, Yonsei University, College of Medicine.
All Science Journal Classification (ASJC) codes